Carla Fiankan brings more than 26 years of experience in providing global regulatory leadership to support the development, registration and life-cycle management of biologics, pharmaceuticals, medical devices and gene therapy products. Throughout her career, Ms. Fiankan has translated regulatory strategies into operational objectives. Prior to joining Adverum, Ms. Fiankan served as vice president of regulatory at InterMune, Inc., responsible for commercial- and development-stage programs, including the registration of Esbriet®. Ms. Fiankan served as the associate director of regulatory affairs at Gilead Sciences, Inc., where she managed regulatory strategies for Gilead’s approved and investigational drugs across the antiviral, cardiovascular, and respiratory franchises. Earlier in her career, she held positions at Amgen Inc., InSite Vision, Inc., and Roche. Ms. Fiankan holds a Bachelor’s degree in Biology from Notre Dame de Namur University and a Master’s degree in Microbiology from San Jose State University.